pillbase.ru

Lojuxta

Active substance: lomitapide

Lomitapide

Centralised EU authorisationActive

Marketing holder: Chiesi Farmaceutici SpA

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 7
  • Juxtapid
    CAPSULE · LOMITAPIDE MESYLATE 30 mg/1
    10122-430
    Chiesi USA, Inc.
  • Juxtapid
    CAPSULE · LOMITAPIDE MESYLATE 2 mg/1
    10122-402
    Chiesi USA, Inc.
  • Juxtapid
    CAPSULE · LOMITAPIDE MESYLATE 10 mg/1
    10122-410
    Chiesi USA, Inc.
  • Juxtapid
    CAPSULE · LOMITAPIDE MESYLATE 5 mg/1
    10122-405
    Chiesi USA, Inc.
  • Juxtapid
    CAPSULE · LOMITAPIDE MESYLATE 20 mg/1
    10122-420
    Chiesi USA, Inc.
All products in this country (7)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-325d-70d3-99a3-7ffba85ab9ff,01a1208c-f608-7221-a6c4-9d7d40585ac1,01a1208d-c4c2-7380-a155-be75030753ca,01a1208d-f95a-76e8-b3c2-959bfbbb4303,01a1208f-7f41-7d17-bf58-d5a4826e3980;count=7 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002578
Registration status
Active
ATC code
C10AX12
Sources
  • product · EMA · EMEA/H/C/002578 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002578 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002578 · Verified 2026-10-09